The Food and Drug Administration rule says over-the-counter consumer antiseptic wash products with one or more of 19 specific active ingredients — including triclosan — can no longer be marketed, according to an article on the Infection Control & Clinical Quality website.
The FDA said soap manufacturers did not demonstrate that the ingredients are both safe for long-term daily use and more effective than plain soap and water.
Manufacturers did not provide necessary data for 19 affected ingredients, which are now banned. They include triclocarban and triclosan.
When the proposed rule was released in 2013, some manufacturers started taking some products containing the banned active ingredients off the market. Now, they will have one year to comply with the final rule.
Rethinking Carpeting's Role in Senior Care Facilities
Parkview Health Breaks Ground on New Hospital in West Lafayette, IN
Loma Linda University Health Experiences Data Breach via AI Tool
Inside One of Healthcare's Most Ambitious Hospital Projects 
Turning Condensate Loss into a Systemwide Steam Efficiency Opportunity